trial · primary record
Inavolisib
Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2031-10-31 |
| Primary endpoint | Percentage of Participants With Objective Response Rate (ORR) |
| Registry ID | NCT07368998 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:13.856Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07368998
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Inavolisib · approval
- Inavolisib · compound